Acute and chronic haemodynamic effects of naftazone in portal hypertensive rats
| Autor: | Richard Moreau, Didier Lebrec, Gilles Avenard, Christophe Pilette, Philippe Sogni, Adrian Gadano, Christian Bloy, Song Yang |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Male
medicine.medical_specialty Cirrhosis Portal venous pressure Hemodynamics Blood Pressure Propranolol Rats Sprague-Dawley Oral administration Internal medicine Hypertension Portal medicine Animals Enzyme Inhibitors Pharmacology business.industry medicine.disease Collateral circulation Rats NG-Nitroarginine Methyl Ester Endocrinology Blood pressure Regional Blood Flow Cardiology Portal hypertension Nitric Oxide Synthase business Naphthoquinones medicine.drug |
| Zdroj: | European Journal of Pharmacology. 344:37-43 |
| ISSN: | 0014-2999 |
| DOI: | 10.1016/s0014-2999(97)01567-7 |
| Popis: | It has been demonstrated that hyperproduction of nitric oxide (NO) plays a major role in the vasodilatation of cirrhosis; thus, the vasodilatation might be reversed by an inhibition of NO production. Experimental studies in isolated aortic rings showed that naftazone inhibits the effects of NO production. The aim of this study was to evaluate the haemodynamic effects of acute and chronic administration of naftazone in rats with portal hypertension. Haemodynamic values were measured either before and 10 min after intravenous administration of 432 microg/kg of naftazone or after 4 days of oral administration of 10 mg/kg per day. Acute administration of naftazone significantly reduced portal pressure in portal vein-stenosed and cirrhotic rats. This reduction was related to a decrease in the resistance of the liver and collateral circulation and it was associated with an increased cardiac output. Oral administration of naftazone significantly decreased portal pressure in rats with portal vein stenosis; this decrease depended on a significant reduction of portal blood flow. In both groups, arterial pressure did not change significantly. These haemodynamic effects differed from those observed following prazosin or propranolol administration. However, these effects were similar but less marked than those observed following N-nitro-L-arginine administration in systemic and splanchnic arterial territories. In conclusion, acute and oral administration of naftazone significantly reduces portal pressure by two different mechanisms in portal hypertensive rats. The exact mechanism has, however, to be elucidated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect